Date: June 22, 2026
Board Meeting Outcomes
Almondz Global Securities Limited has received in-principle approval from both BSE Limited and National Stock Exchange of India Limited for a proposed preferential issue of securities:
- Approval from BSE Limited: Letter No. LOD/PREF/PB/FIP/410/2026-27 dated June 19, 2026
- Approval from NSE: Letter No. NSE/LIST/53806 dated June 19, 2026
- Securities to be issued: 80,00,000 warrants convertible into 80,00,000 equity shares of ₹1 each
- Issue price: Not less than ₹16.58 per equity share
- Allottees: Non-promoters on a preferential basis
Regulatory Compliance Requirements
Both exchanges have specified conditions and compliance requirements:
BSE Requirements:
- Issue and allotment must comply with Companies Act 2013, SCRA 1956, SEBI Act 1992, Depositories Act 1996, SEBI ICDR Regulations 2018, and SEBI LODR Regulations 2015
- Company must strengthen internal controls to monitor trades executed by proposed allottees
- Must obtain undertaking from allottees confirming they will not do intra-day trading or any sale in the company scrip until allotment date
- Responsibility solely on issuer company to verify compliance with Regulation 167(6) of SEBI ICDR regulations, 2018
- Non-compliances may impact listing of shares
- Listing application must be made without delay after allotment with applicable fees under Regulation 14 of LODR Regulations
NSE Requirements:
- Filing listing application earliest from date of allotment
- Receipt of statutory and other approvals from SEBI, RBI, MCA, etc.
- Compliance with all applicable guidelines, regulations, and directions of Exchange or statutory authorities
- Compliance with SEBI LODR Regulations 2015, Companies Act 1956/2013, and other applicable laws
- Submission of required documents and payment of applicable fees
Post-Allotment Timeline:
- Application for listing must be made within twenty days from date of allotment as per SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023
Exchange Rights:
Both exchanges reserve the right to withdraw in-principle approval if information submitted is found incomplete/incorrect/misleading/false or contravenes any rules, regulations, or guidelines.